Abstract | INTRODUCTION:
Tranexamic acid (TXA) reduces blood loss and blood transfusion requirements in surgery. Seroma and haematoma formation occur as complications of breast surgery. We aimed to perform a meta-analysis evaluating TXA in reducing post-operative haematoma and seroma formation for breast surgery. METHODS: A systematic review was performed in accordance with PRISMA guidelines. Results were expressed as dichotomous variables pooled as odds ratios (OR) with corresponding 95% confidence intervals (CIs) using the Mantel-Haenszel method. RESULTS: Seven studies including 1446 patients were included. There were 1830 breast surgery procedures performed with TXA administered in 797 cases (43.6%). There was a significant reduction in haematoma rates in the TXA group (TXA: 3.184% (22/691) vs Control: 6.787% (64/943), OR: 0.41, 95% CI: 0.20-0.86, P = 0.020). Based on surgical procedure, haematoma rates were similar for TXA and control groups in cancer surgery (P = 0.230). Haematoma rates reduced following TXA use in cosmetic procedures (TXA: 3.807% (15/394) vs. Control: 9.091% (34/374), OR: 0.41, 95% CI: 0.22-0.75, P = 0.004). Haematoma rates were also reduced in procedures where axillary lymph node dissection (ALND) was not performed; in the TXA group, 3.379% (22/651) developed a haematoma versus 6.623% (60/906) in the control group (OR: 0.45, 95% CI 0.27-0.77, P = 0.003). TXA administration did not impact seroma formation or infection rates. CONCLUSION: Perioperative administration of TXA may impact the incidence of haematoma in breast surgery, particularly in cosmetic procedures and procedures without ALND. Well-designed randomised studies are required to determine its true efficacy. TXA has no effect on seroma formation or infection in breast surgery.
|
Authors | Gavin G Calpin, Peter F McAnena, Matthew G Davey, Pádraig Calpin, Michael J Kerin, Niall McInerney, Stewart R Walsh, Aoife J Lowery |
Journal | The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland
(Surgeon)
Vol. 21
Issue 4
Pg. e183-e194
(Aug 2023)
ISSN: 1479-666X [Print] Scotland |
PMID | 36572609
(Publication Type: Systematic Review, Meta-Analysis, Journal Article, Review)
|
Copyright | Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved. |
Chemical References |
- Tranexamic Acid
- Antifibrinolytic Agents
|
Topics |
- Humans
- Female
- Tranexamic Acid
(therapeutic use)
- Antifibrinolytic Agents
(therapeutic use)
- Seroma
(etiology, prevention & control)
- Blood Loss, Surgical
(prevention & control)
- Hematoma
(prevention & control)
- Breast Neoplasms
(surgery)
|